Frank Behrens

Goethe University Frankfurt — Germany

Medicine · Health Sciences

36h-index7.3kcitations307works6.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(154), Psoriasis: Treatment and Pathogenesis(148), Spondyloarthritis Studies and Treatments(146), Autoimmune and Inflammatory Disorders Research(86), Systemic Lupus Erythematosus Research(21)

Publications307 total

Psoriatic Arthritis (PsA) Clinical Lipidomics Dataset with Hidden Laboratory Workflow Artifacts: A Benchmark Dataset for Data Processing Quality Control in Lipidomics
Data·2026Open Access
Effect of thyme-ivy syrup on antiviral immune response in patients with mild COVID-19: a prospective, open-label, randomized pilot study
Frontiers in Medicine·2025Open Access
Real-world sex differences in treatment persistence and reasons for discontinuation in psoriatic arthritis patients: results from the German RABBIT-SpA register
Arthritis Research & Therapy·2025Open Access
Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies
RMD Open·2025· 1 citedOpen Access
Guselkumab and Il-17 Inhibitors Improve Patient-Perceived Impact of Psoriatic Arthritis Similarly: 6 Month Interim Results of the PsABIOnd Observational Cohort Study
The Journal of Rheumatology·2025Open Access
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study
The Lancet Rheumatology·2025· 6 citedOpen Access
Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumab
Therapeutic Advances in Musculoskeletal Disease·2025· 2 citedOpen Access
POS0242 MECHANICAL FORCES TRIGGER INVASIVE BEHAVIOUR IN SYNOVIAL FIBROBLASTS THROUGH N-CADHERIN/ADAM15-DEPENDENT MODULATION OF lncRNA H19 IN RHEUMATOID ARTHRITIS
Annals of the Rheumatic Diseases·2025Open Access
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease
Autoimmunity Reviews·2025· 3 citedOpen Access
Efficacy and safety of izokibep in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
Annals of the Rheumatic Diseases·2025· 7 citedOpen Access
Real-World Effectiveness and Tolerability of Apremilast in Psoriatic Arthritis in Germany: Results from LAPIS-PsA
The Open Rheumatology Journal·2025Open Access
E090 Guselkumab and IL-17 inhibitors improve patient-perceived impact of psoriatic arthritis similarly: 6-month interim results of the PsABIOnd observational cohort study
Lara D. Veeken·2025Open Access
P167 Guselkumab and IL-17 inhibitors show comparable treatment persistence and effectiveness in psoriatic arthritis outcomes: 6-month interim results of the PsABIOnd observational cohort study
Lara D. Veeken·2025Open Access
Mechanical forces trigger invasive behavior in synovial fibroblasts through N-cadherin/ADAM15 -dependent modulation of LncRNA H19
Scientific Reports·2025· 6 citedOpen Access
Psoriasis und Psoriasis-Arthritis: Unklare Datenlage zur Prävention der Gelenkbeteiligung
Deutsches Ärzteblatt·2025Open Access
GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets
Nature Communications·2025· 38 citedOpen Access
Verlauf der psoriatischen Erkrankung: Prävention der Psoriasis-Arthritis möglicherweise bald greifbar
Deutsches Ärzteblatt·2025Open Access
Proteomic, metabolomic and lipidomic profiles in community acquired pneumonia for differentiating viral and bacterial infections
Scientific Reports·2025· 5 citedOpen Access
When Artifacts Masquerade as Discovery: A Case Study Revealing Hidden Laboratory Errors in Lipidomics Data with Biologically Apparently Plausible Results
SSRN Electronic Journal·2025Open Access
Caractéristiques des patients atteints de rhumatisme psoriasique traités par Guselkumab ou par un inhibiteur de l’IL-17 : résultats de l’étude observationnelle multicentrique PsABIOnd en cours
Revue du Rhumatisme·2024
page 1 of 16Next →

Frequent Co-authors

Harald Burkhardt(14), Peter Nash(11), Ulrike Hüffmeier(9), André Reis(9), Philip J. Mease(9), Neil McHugh(9), John Bowes(8), Steffen Uebe(8), Oliver FitzGerald(8), Anne Barton(8), Dafna D. Gladman(8), Ross McManus(7), Pauline Ho(7), Philip Helliwell(6), Richard B. Warren(6), Eleanor Korendowych(6), Emiliano Giardina(6), Diamant Thaçi(6), Iain B. McInnes(6), Ian N Bruce(5)